S&P 500   3,000.47 (+1.16%)
DOW   27,075.06 (+1.07%)
QQQ   193.82 (+1.43%)
AAPL   235.96 (+0.04%)
FB   189.31 (+3.29%)
MSFT   141.59 (+1.46%)
GOOGL   1,245.78 (+2.30%)
AMZN   1,774.42 (+2.19%)
NVDA   196.91 (+5.56%)
MU   46.52 (+3.70%)
BABA   175.01 (+2.25%)
GE   8.87 (+1.60%)
AMD   30.76 (+0.75%)
T   37.94 (+1.25%)
F   9.08 (+2.83%)
ACB   3.81 (+8.55%)
PRI   123.64 (+1.79%)
NFLX   283.80 (-0.61%)
BAC   29.96 (+2.78%)
GILD   65.57 (+1.63%)
DIS   130.41 (+0.55%)
S&P 500   3,000.47 (+1.16%)
DOW   27,075.06 (+1.07%)
QQQ   193.82 (+1.43%)
AAPL   235.96 (+0.04%)
FB   189.31 (+3.29%)
MSFT   141.59 (+1.46%)
GOOGL   1,245.78 (+2.30%)
AMZN   1,774.42 (+2.19%)
NVDA   196.91 (+5.56%)
MU   46.52 (+3.70%)
BABA   175.01 (+2.25%)
GE   8.87 (+1.60%)
AMD   30.76 (+0.75%)
T   37.94 (+1.25%)
F   9.08 (+2.83%)
ACB   3.81 (+8.55%)
PRI   123.64 (+1.79%)
NFLX   283.80 (-0.61%)
BAC   29.96 (+2.78%)
GILD   65.57 (+1.63%)
DIS   130.41 (+0.55%)
Log in

Allergy Therapeutics News Headlines (LON:AGY)

GBX 12.15
0.00 (0.00 %)
(As of 10/15/2019 02:56 PM ET)
Today's Range
12.08
Now: GBX 12.15
12.08
50-Day Range
11.15
MA: GBX 12.17
13.20
52-Week Range
8
Now: GBX 12.15
22.50
Volume2,439 shs
Average Volume167,682 shs
Market Capitalization£77.29 million
P/E Ratio24.30
Dividend YieldN/A
BetaN/A

Headlines

Allergy Therapeutics (LON AGY) News Headlines

Source:
DateHeadline
Edited Transcript of AGY.L earnings conference call or presentation 25-Sep-19 8:30am GMTEdited Transcript of AGY.L earnings conference call or presentation 25-Sep-19 8:30am GMT
finance.yahoo.com - September 27 at 10:43 PM
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market shareHardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share
www.marketwatch.com - September 26 at 4:57 AM
Allergy Therapeutics Looking To Chinese Market As It Swings To ProfitAllergy Therapeutics Looking To Chinese Market As It Swings To Profit
www.morningstar.co.uk - September 25 at 7:50 AM
Allergy Therapeutics (LON:AGY) Earns Corporate Rating from FinnCapAllergy Therapeutics (LON:AGY) Earns Corporate Rating from FinnCap
www.americanbankingnews.com - September 25 at 6:32 AM
Health Check: How Prudently Does Allergy Therapeutics (LON:AGY) Use Debt?Health Check: How Prudently Does Allergy Therapeutics (LON:AGY) Use Debt?
finance.yahoo.com - September 12 at 8:53 AM
Did Changing Sentiment Drive Allergy Therapeuticss (LON:AGY) Share Price Down A Worrying 57%?Did Changing Sentiment Drive Allergy Therapeutics's (LON:AGY) Share Price Down A Worrying 57%?
finance.yahoo.com - July 23 at 11:13 AM
Did Changing Sentiment Drive Allergy Therapeutics's (LON:AGY) Share Price Down A Worrying 57%?Did Changing Sentiment Drive Allergy Therapeutics's (LON:AGY) Share Price Down A Worrying 57%?
finance.yahoo.com - July 23 at 11:13 AM
CORRECT (JUL 11): Allergy Therapeutics To Outperform Market ViewsCORRECT (JUL 11): Allergy Therapeutics To Outperform Market Views
www.morningstar.co.uk - July 12 at 9:28 AM
Allergy Therapeutics Expects To Outperform Market ExpectationsAllergy Therapeutics Expects To Outperform Market Expectations
www.morningstar.co.uk - July 11 at 9:21 AM
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertaintyHardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
www.marketwatch.com - July 1 at 9:30 AM
Allergy Therapeutics plc - Trading Update and Successful Litigation SettlementAllergy Therapeutics plc - Trading Update and Successful Litigation Settlement
finance.yahoo.com - June 27 at 5:36 PM
Allergy Therapeutics plc - Successful litigation settlement relating to PQ Grass Phase II TrialAllergy Therapeutics plc - Successful litigation settlement relating to PQ Grass Phase II Trial
finance.yahoo.com - June 27 at 5:36 PM
Allergy Therapeutics Settles Grass Trial Litigation; Confident In YearAllergy Therapeutics Settles Grass Trial Litigation; Confident In Year
www.morningstar.co.uk - June 27 at 9:43 AM
Allergy Therapeutics Hires Former Advanced Medical Solutions CFOAllergy Therapeutics Hires Former Advanced Medical Solutions CFO
www.morningstar.co.uk - June 19 at 12:05 PM
Hardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progressHardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress
www.marketwatch.com - May 21 at 11:28 AM
Allergy Therapeutics Vaccine Helps Dust Mite Allergy Symptoms In StudyAllergy Therapeutics Vaccine Helps Dust Mite Allergy Symptoms In Study
www.morningstar.co.uk - May 20 at 12:31 PM
SkyGem Acquisition Builds 12% Interest In Allergy Therapeutics (ALLISS)SkyGem Acquisition Builds 12% Interest In Allergy Therapeutics (ALLISS)
www.morningstar.co.uk - May 14 at 7:05 PM
Allergy Therapeutics Publishes New Research Exploring Potential of its Adjuvant Systems in the Treatment of Cancer in the Journal of ImmunoTherapy of CancerAllergy Therapeutics Publishes New Research Exploring Potential of its Adjuvant Systems in the Treatment of Cancer in the Journal of ImmunoTherapy of Cancer
finance.yahoo.com - May 7 at 9:28 AM
How Does Investing In Allergy Therapeutics plc (LON:AGY) Impact The Volatility Of Your Portfolio?How Does Investing In Allergy Therapeutics plc (LON:AGY) Impact The Volatility Of Your Portfolio?
finance.yahoo.com - May 6 at 9:34 AM
Allergy Therapeutics Phase Three PQ Grass Trial Scheduled For 2020Allergy Therapeutics Phase Three PQ Grass Trial Scheduled For 2020
www.morningstar.co.uk - April 25 at 6:12 PM
Allergy Therapeutics plc (lon:AGY) price target lowered to GBX 40 by FinnCapAllergy Therapeutics plc (lon:AGY) price target lowered to GBX 40 by FinnCap
www.marketwatch.com - March 22 at 6:12 PM
Allergy Therapeutics Surprised As Vaccine Trial Fails Primary EndpointAllergy Therapeutics Surprised As Vaccine Trial Fails Primary Endpoint
www.morningstar.co.uk - March 18 at 9:18 AM
Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective viewHardman & Co Research: Allergy Therapeutics (AGY): Take an objective view
www.marketwatch.com - March 18 at 9:18 AM
Hardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market shareHardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market share
www.marketwatch.com - March 6 at 9:42 AM
Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market shareHardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share
www.finanznachrichten.de - January 17 at 10:15 AM
Allergy Therapeutics First Half Meets Forecasts On European GrowthAllergy Therapeutics First Half Meets Forecasts On European Growth
www.morningstar.co.uk - January 16 at 9:24 AM
What Investors Should Know About Allergy Therapeutics plc’s (LON:AGY) Financial StrengthWhat Investors Should Know About Allergy Therapeutics plc’s (LON:AGY) Financial Strength
finance.yahoo.com - November 13 at 4:32 PM
Allergy Therapeutics Appoints Scott Leinenweber As Non-ExecutiveAllergy Therapeutics Appoints Scott Leinenweber As Non-Executive
www.morningstar.co.uk - November 8 at 4:44 PM
BlackRock Lowers Allergy Therapeutics Stake Below Threshold (ALLISS)BlackRock Lowers Allergy Therapeutics Stake Below Threshold (ALLISS)
www.morningstar.co.uk - October 23 at 4:21 PM
Hardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growthHardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growth
www.finanznachrichten.de - September 27 at 9:22 AM
Can Allergy Therapeutics plc (LON:AGY) Improve Your Portfolio Returns?Can Allergy Therapeutics plc (LON:AGY) Improve Your Portfolio Returns?
finance.yahoo.com - September 26 at 9:34 AM
Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in ImmunotherapyAllergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy
globenewswire.com - June 25 at 11:08 AM
Allergy Therapeutics plc - Positive new data with house-dust mite immunotherapyAllergy Therapeutics plc - Positive new data with house-dust mite immunotherapy
globenewswire.com - May 29 at 9:18 AM
Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registrationHardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration
www.finanznachrichten.de - May 21 at 9:16 AM
Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging studyAllergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study
globenewswire.com - May 21 at 9:16 AM
Has Allergy Therapeutics plc (LON:AGY) Improved Earnings Growth In Recent Times?Has Allergy Therapeutics plc (LON:AGY) Improved Earnings Growth In Recent Times?
finance.yahoo.com - May 17 at 9:44 AM
Allergy Therapeutics to Present at Jefferies 2017 - London South East (blog)Allergy Therapeutics to Present at Jefferies 2017 - London South East (blog)
www.lse.co.uk - November 14 at 4:23 AM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 10, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 10, 2017
finance.yahoo.com - November 10 at 2:37 PM
Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 2, 2017Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 2, 2017
finance.yahoo.com - November 2 at 9:02 PM
Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: 2017 By the Numbers : October 24, 2017Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: 2017 By the Numbers : October 24, 2017
finance.yahoo.com - October 24 at 9:35 PM
Allergy Thera. Share ChatAllergy Thera. Share Chat
www.lse.co.uk - October 24 at 2:48 AM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 24, 2016Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 24, 2016
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : January 9, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : January 9, 2017
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : January 10, 2017Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : January 10, 2017
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics: Positive Efficacy and Safety Data Shown in Peanut Allergy VaccineAllergy Therapeutics: Positive Efficacy and Safety Data Shown in Peanut Allergy Vaccine
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : March 23, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : March 23, 2017
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : May 5, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : May 5, 2017
finance.yahoo.com - October 5 at 12:58 PM
Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : May 8, 2017Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : May 8, 2017
finance.yahoo.com - October 5 at 12:58 PM
Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended December 31, 2016 : May 12, 2017Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended December 31, 2016 : May 12, 2017
finance.yahoo.com - October 5 at 12:58 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : May 18, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : May 18, 2017
finance.yahoo.com - October 5 at 12:58 PM
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel